257 related articles for article (PubMed ID: 34126355)
21. MAGI2-AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR-525-5p/MXD1 axis.
Chang H; Zhang X; Li B; Meng X
Cancer Med; 2020 Sep; 9(17):6377-6386. PubMed ID: 32681706
[TBL] [Abstract][Full Text] [Related]
22. Long Noncoding RNA MAGI2-AS3 Represses Cell Progression in Clear Cell Renal Cell Carcinoma by Modulating the miR-629-5p/PRDM16 Axis.
Yan C; Wang P; Zhao C; Yin G; Meng X; Li L; Cai S; Meng B
Crit Rev Eukaryot Gene Expr; 2023; 33(7):43-56. PubMed ID: 37602452
[TBL] [Abstract][Full Text] [Related]
23. Targeting MAGI2-AS3-modulated Akt-dependent ATP-binding cassette transporters as a possible strategy to reverse temozolomide resistance in temozolomide-resistant glioblastoma cells.
Chen Z; Zhou J; Liu Y; Ni H; Zhou B
Drug Dev Res; 2023 Nov; 84(7):1482-1495. PubMed ID: 37551766
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
Zhang X; Jiang Y; Xie Y; Leng X; Song F
DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters.
Záveský L; Jandáková E; Weinberger V; Minář L; Kohoutová M; Slanař O
Cancer Biomark; 2024; 40(1):61-78. PubMed ID: 38277283
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA MAGI2-AS3 inhibits breast cancer cell migration and invasion via sponging microRNA-374a.
Du S; Hu W; Zhao Y; Zhou H; Wen W; Xu M; Zhao P; Liu K
Cancer Biomark; 2019; 24(3):269-277. PubMed ID: 30883342
[TBL] [Abstract][Full Text] [Related]
27. Identification and Verification of a Novel MAGI2-AS3/miRNA-374-5p/FOXO1 Network Associated with HBV-Related HCC.
Wang C; Su K; Lin H; Cen B; Zheng S; Xu X
Cells; 2022 Nov; 11(21):. PubMed ID: 36359865
[TBL] [Abstract][Full Text] [Related]
28. MAGI2-AS3 and miR-374b-5p as Putative Regulators of Multiple Sclerosis via Modulating the PTEN/AKT/IRF-3/IFN-β Axis: New Clinical Insights.
Kortam MA; Elfar N; Shaker OG; El-Boghdady NA; Abd-Elmawla MA
ACS Chem Neurosci; 2023 Mar; 14(6):1107-1118. PubMed ID: 36878000
[TBL] [Abstract][Full Text] [Related]
29. LncRNA MAGI2-AS3 inhibits hepatocellular carcinoma cell proliferation and migration by targeting the miR-374b-5p/SMG1 signaling pathway.
Yin Z; Ma T; Yan J; Shi N; Zhang C; Lu X; Hou B; Jian Z
J Cell Physiol; 2019 Aug; 234(10):18825-18836. PubMed ID: 30924168
[TBL] [Abstract][Full Text] [Related]
30. Expression of long non-coding RNA MAGI2‑AS3 in human gliomas and its prognostic significance.
Chen XD; Zhu MX; Wang SJ
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3455-3460. PubMed ID: 31081100
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA (lncRNA) MAGI2-AS3 inhibits breast cancer cell growth by targeting the Fas/FasL signalling pathway.
Yang Y; Yang H; Xu M; Zhang H; Sun M; Mu P; Dong T; Du S; Liu K
Hum Cell; 2018 Jul; 31(3):232-241. PubMed ID: 29679339
[TBL] [Abstract][Full Text] [Related]
32. LncRNA MAGI2-AS3 inhibits tumor progression and angiogenesis by regulating ACY1 via interacting with transcription factor HEY1 in clear cell renal cell carcinoma.
Wang G; Li H; Hou Y
Cancer Gene Ther; 2022 May; 29(5):585-596. PubMed ID: 34002044
[TBL] [Abstract][Full Text] [Related]
33. Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
Zhang J; Wang R
Exp Gerontol; 2021 Feb; 144():111180. PubMed ID: 33279663
[TBL] [Abstract][Full Text] [Related]
34. LncRNA MAGI2-AS3 promotes fracture healing through downregulation of miR-223-3p.
Dong Z; Hu B; Wang S; Wang M; Sun S; Liu X; Li D; Wu D
J Orthop Surg Res; 2024 Jun; 19(1):370. PubMed ID: 38907263
[TBL] [Abstract][Full Text] [Related]
35. LncRNA MAGI2-AS3 is downregulated in the distant recurrence of hepatocellular carcinoma after surgical resection and affects migration and invasion via ROCK2.
Fang G; Wang J; Sun X; Xu R; Zhao X; Shao L; Sun C; Wang Y
Ann Hepatol; 2020; 19(5):535-540. PubMed ID: 32546442
[TBL] [Abstract][Full Text] [Related]
36. LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a.
Li D; Wang J; Zhang M; Hu X; She J; Qiu X; Zhang X; Xu L; Liu Y; Qin S
Mol Ther Nucleic Acids; 2020 Mar; 19():109-123. PubMed ID: 31837602
[TBL] [Abstract][Full Text] [Related]
37. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis.
Hao XZ; Yang K
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7399-7407. PubMed ID: 31539127
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding MAGI2-AS3 promotes colorectal cancer progression through regulating miR-3163/TMEM106B axis.
Ren H; Li Z; Tang Z; Li J; Lang X
J Cell Physiol; 2020 May; 235(5):4824-4833. PubMed ID: 31709544
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA MAGI2-AS3 regulates the H
Zhang Y; Qiao X; Liu L; Han W; Liu Q; Wang Y; Xie T; Tang Y; Wang T; Meng J; Ye A; He S; Chen R; Chen C
Redox Biol; 2022 Aug; 54():102383. PubMed ID: 35797800
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer.
Yang G; Chen X; Quan Z; Liu M; Guo Y; Tang Y; Peng L; Wang L; Wu Y; Wu X; Liu J; Zheng Y
Front Oncol; 2023; 13():1048521. PubMed ID: 36998469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
